| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780075 | Gynecologic Oncology | 2018 | 8 Pages |
Abstract
PIPAC with cisplatin and doxorubicin may be safely used at an intraperitoneal dose of 10.5â¯mg/m2 and 2.1â¯mg/m2, respectively. Systemic toxicity of this therapy is low.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Clemens B. Tempfer, Urs Giger-Pabst, Veronika Seebacher, Miriam Petersen, Askin Dogan, Günther A. Rezniczek,